Pre-"EMT"ing key processes in liver carcinogenesis: Growing evidence for how malignant hepatocytes invade and conquer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma.Oncotarget · 2017
   Article
2. HBV induced HCC: major risk factors from genetic to molecular level.BioMed research international · 2013
   Review
3. Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein.Cancer science · 2012
   Article

Corrections and comments

• Comment on
  CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.